Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide

@article{Koh2009LowIO,
  title={Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide},
  author={Youngil Koh and Soo Mee Bang and Jae Hoon Lee and H Yoon and Young-Rok Do and H L Ryoo and Nari Lee and Seok Jin Kim and Kihyun Kim and Sung Soo Yoon and Jong-Ho Won and Yeung-Chul Mun and Moon Hee Lee and K J Rhee and Hyo-Jung Kim and Hyeon Seok Eom and Min Kyoung Kim and Hyun Chun Shin},
  journal={Annals of Hematology},
  year={2009},
  volume={89},
  pages={201-206}
}
The frequency of thromboembolic events (TE) in Caucasian patients with multiple myeloma (MM) receiving thalidomide as the initial treatment has been reported to be 10~58% without prophylactic anticoagulation. Korean MM patients treated with thalidomide were studied to determine the frequency of TE and associated risk factors. A retrospective medical record… CONTINUE READING